HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 23, No 08, August 2019 – Digitalization vs Digitization — Exploring Emerging Trends in Healthcare       » Shanghai neurologists test brain implant to tackle drug addiction       » Gene-editing researchers reduce cancer risk       » Artificial Intelligence in Precision Cancer Diagnostics: Myth or Magic?       » Healing with Technology       » Smart Hospital: An Instrument of Care       » Transforming Healthcare with Data and Artificial Intelligence      
ASIA-PACIFIC
Singapore scientists uncover mechanism behind development of viral infections
Clinical trial findings provide new insights to differential responses to flaviviral infections.

A team of researchers from
the SingHealth Duke-NUS
Academic Medicine Centre’s Viral Research and Experimental Medicine Centre (ViREMiCS) found that immune cells undergoing stress and an altered metabolism are the reasons why some individuals become sick from viral infections while others do not, when exposed to the same virus.

The findings have important implications for the prevention and treatment of infectious diseases caused by flaviviral infections such as dengue fever, congenital Zika syndrome and yellow fever. Flaviviral infections, a family of virus infections transmitted by mosquitoes and ticks, are major health concerns as they spread rapidly and lack licensed treatments.

Most viral infections result in a range of outcomes even when individuals are infected with the same amount of virus in their blood. For example, up to two-thirds of all dengue virus infections result in no symptoms, while the remaining one-third go on to develop dengue fever and even fewer progress to severe dengue. Understanding why this happens could lead to new ways of preventing disease and reduce the burden of some viral diseases.

“We investigated why some individuals do not get sick despite being infected with the same virus, while others develop symptoms and infections. Understanding the molecular events that lead to development of symptoms could lead to new prevention and treatment methods for infectious diseases worldwide,” said Professor Ooi Eng Eong, Deputy Director of the Emerging Infectious Diseases (EID) Programme, Duke-NUS Medical School and Professor, SingHealth Duke-NUS Global Health Institute. Prof Ooi is also Co-director of ViREMiCS, Professor at the Saw Swee Hock School of Public Health and the Department of Microbiology & Immunology, National University of Singapore and the corresponding author of this study.

The team conducted two clinical trials involving more than 100 healthy adults using the yellow fever vaccine, one of the most effective vaccines in the world with an excellent safety profile. The team analysed the blood profiles of the volunteers immediately before and after vaccination and found that individuals whose blood cells had increased levels of stress from protein production and altered metabolism before vaccination went on to develop flu-like symptoms after vaccination. Increased stress and altered metabolism resulted in earlier than expected activation of the immune response that was linked with development of symptoms.

“Our findings show that increased levels of stress and altered metabolism of an individual’s immune cells are factors that make one prone to developing symptoms during an infection.

Correspondingly, this tells us that immune cells and metabolic pathways could be useful targets to develop treatments for yellow fever or other flaviviral infections,” said Associate Professor Jenny Low, Senior Consultant at the Department of Infectious Diseases, Singapore General Hospital and Co-Director of ViREMiCS. Dr Low is also Associate Professor at Duke-NUS’ EID Programme and co-corresponding author of this study.

These findings also imply that preventing conditions known to place cells under increased stress and altered metabolism, such as obesity, could prevent disease from viral infections.

The team is currently starting another clinical trial in 2020 to test if suppressing the early immune response can reduce the likelihood of getting sick from a viral infection.

Click here for the complete issue.

NEWS CRUNCH  
news How blockchain can save the food industry millions from recalls
news China Healthcare and Pharma Digital Innovation Summit
news BIO-PHARM2019 — The Most Influential Forum in China's Biopharm Industry
news The rise of personalised nutrition
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
SPOTLIGHT  
LIFE OF A SCIENTIST  

APBN Editorial Calendar 2019
January:
Taiwan Medical tourism
February:
Marijuana as medicine — Legal marijuana will open up scientific research
March:
Driven by curiosity
April:
Career developments for researchers
May:
What's cracking — Antibodies in ostrich eggs
June:
Clinical trials — What's in a name?
July:
Traditional Chinese medicine in modern healthcare — Integrating both worlds
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy